John Solomon MD

John Solomon joined Sanofi in 2005 as the Head of Pharmacovigilance at the UK Affiliate with responsibility for pre/post-authorization drug surveillance activities for a large portfolio of innovative, generic, GSL medicines and medical devices. He is Qualified in medicine, John has worked for 15 years in the Pharmaceutical industry spending the last 10 of these years in clinical drug safety and post-marketing drug surveillance activities. Other industry-related experience includes pharmaceutical marketing and managing global clinical-drug safety programs in the Pharmaceutical industry and CRO sectors respectively.

John has over the years interfaced with UK Regulators on various Agency/industry initiatives including the Pharmacovigilance (PV) Better Regulation of Medicines Initiative (BROMI) workstream in the UK, the lay summary “Risk Management Plan”, Forum on Benefit-Risk decision analysis, and more recently the New PV legislation. John is currently an industry representative on various UK trade associations and PV networks. John is especially committed to transparency around patient-centric Pharmacovigilance.